Home/Filings/4/0001415889-25-005920
4//SEC Filing

Wainer Andrea F 4

Accession 0001415889-25-005920

CIK 0000001800other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 6:56 PM ET

Size

7.5 KB

Accession

0001415889-25-005920

Insider Transaction Report

Form 4
Period: 2025-02-25
Wainer Andrea F
EXECUTIVE VICE PRESIDENT
Transactions
  • Award

    Common shares without par value

    2025-02-25+12,27882,643 total
  • Award

    Option (right to buy)

    2025-02-25+45,73045,730 total
    Exercise: $135.42From: 2026-02-25Exp: 2035-02-24Common Shares (45,730 underlying)
Footnotes (2)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,243 on February 25, 2026, 15,243 on February 25, 2027, and 15,244 on February 25, 2028.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001778070

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:56 PM ET
Size
7.5 KB